0
Editor's Correspondence |

Group A Streptococcal Pneumonia—Reply

Matthew P. Muller, MD, FRCPC; Allison McGeer, MD, FRCPC
Arch Intern Med. 2003;163(17):2101-2102. doi:10.1001/archinte.163.17.2101-a.
Text Size: A A A
Published online

Extract

In reply

Dr Mulla's data from a population-based surveillance of invasive GAS infection in Florida, conducted between 1996 and 2000, appears to corroborate our findings of a high case fatality rate associated with invasive GAS infection presenting as pneumonia. Dr Mulla's comment about fluoroquinolone use in his cohort prompted us to reexamine our data. Unfortunately, in our cohort of patients with GAS pneumonia, only 18 (8%) received initial empiric therapy that included a fluoroquinolone and only 3 (1.4%) received initial monotherapy with a fluoroquinolone.1 For this reason, we cannot comment on outcomes specifically associated with treatment of GAS pneumonia with fluoroquinolones. The rapid progression from diagnosis to death in many of our cases suggests, however, that major differences in outcome between different classes of antibiotics are not likely to occur. As we suggested in our article, "New therapies instituted early in the disease process will be required before improvements in outcome will be seen."1 All patients should receive an antibiotic with proven efficacy against GAS infection.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com
brightcove.createExperiences();